Future Trends in Breast Cancer Management
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Oncology".
Deadline for manuscript submissions: 31 January 2025 | Viewed by 881
Special Issue Editor
Interests: breast cancer; breast reconstruction; lipomodelling
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Breast cancer is one of the most common adult cancers worldwide with more than 2.3 million cases of breast cancer occurring each year. The management of breast cancer is a quickly changing field. The adoption of newer technologies and quality research has helped better diagnosis, prognostication, and treatments. In addition, there have been advancements in the availability of wider targeted therapies to treat breast cancer with improved outcomes. Ongoing research in various fields and a better understanding of this heterogeneous disease is helping to adopt various de-escalation treatment settings. Further research into various subsets of breast cancer patients would be of interest, such as Her2-low breast cancer patients and treatment outcomes with various antibody drug conjugates. Artificial intelligence and digital technology will significantly influence the management of breast cancer in the future. This may be of great help to achieve a consistent improved cancer survival with better patient outcomes being reported across the globe. Advancements in radiomics may enable us to decipher the histological nature of the disease without invasive tissue biopsies.
Dr. Dinesh K. Thekkinkattil
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- breast cancer
- breast reconstruction
- artificial intelligence
- machine learning
- staging
- treatment
- targeted therapy
- digital pathology
- radiomics
- oncoplastic surgery
- prognosis
- immunotherapy
- liquid biopsy
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.